BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 20162521)

  • 1. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antileukotrienes in the therapy of bronchial asthma].
    Riccioni G; Della Vecchia R; Menna V; Lambo MS; Di Ilio C; D'Orazio N
    Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antileukotrienes in asthma - critical view].
    Droszcz W
    Pneumonol Alergol Pol; 2010; 78(1):60-7. PubMed ID: 20162520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukotriene agents in asthma: the dart that kills the elephant?
    Renzi PM
    CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
    Wagener M
    Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current recommendation for asthma treatment].
    Kuna P
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():24-9. PubMed ID: 15524009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-leukotrienes: a new class of drugs to integrate into the therapeutic strategy of asthma].
    Fellrath JM; Leuenberger P; Weilenmann C; Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):217-26. PubMed ID: 10218418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of leukotrienes in asthma.
    Wenzel SE
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):145-55. PubMed ID: 12895597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary therapy in asthma: inhaled corticosteroids and what?
    Bjermer L; Diamant Z
    Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating asthma: is there a place for leukotriene receptor antagonists?
    Diamant Z; van der Molen T
    Respir Med; 2005 Jun; 99(6):655-62. PubMed ID: 15878481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis].
    Mastalerz L; Kania A
    Pneumonol Alergol Pol; 2010; 78(1):74-8. PubMed ID: 20162522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in antileukotriene therapy.
    Scadding GW; Scadding GK
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):370-6. PubMed ID: 20585242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L; Diamant Z
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.